Sonic Healthcare (ASX:SHL) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:SHL Sonic Healthcare Ltd ASX:SHL
80 GF Score
Price A$21.88
GF Value A$33.06
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Sonic Healthcare FFO per Share?

FFO per Share only applies to REITs.

ASX:SHL
80GF Score
Sonic Healthcare Ltd ASX:SHL
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sonic Healthcare (ASX:SHL) Overvalued in 2026?

Based on GuruFocus' analysis, Sonic Healthcare stock appears to be undervalued. The current stock price of A$21.88 is trading 33.8% below its estimated GF Value™ of A$33.06. GuruFocus considers Sonic Healthcare to be Significantly Undervalued.

Key valuation signals for ASX:SHL:

  • FFO per Share:
  • GF Value™: A$33.06 vs. price of A$21.88 (33.8% below fair value)
  • GF Score™: 80/100 with 5 warning signs

No single metric tells the full story. See the ASX:SHL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sonic Healthcare Business Description

Address 225 George Street, Level 22, Grosvenor Place, Sydney, NSW, AUS, 2000
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third largest in the US. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 35% of group revenue in Australia and New Zealand, 25% in the US, and 40% in Europe.
80GF Score

Get the complete analysis for ASX:SHL

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$21.88
Price
A$33.06
GF Value